BCRX vs EMN · rev $374.7M vs P/E 21, rev $9.38B
BioCryst Pharmaceuticals Inc (BCRX) versus Eastman Chemical Company (EMN) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
BCRX currently screens at market cap $1.83B. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Not investment advice. Open the BCRX and EMN stock pages for the full models.
Not investment advice.